$VRTX 8-K SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers (d) On October 20, 2026, Daniel Brennan was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”). In connection with the appointment of Mr. Brennan, the size of the Boar...
01 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation
03 Aug 2026	8-K: Results of Operations and Financial Condition
07 Jul 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
13 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
04 May 2026	8-K: Results of Operations and Financial Condition
29 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
31 Mar 2026	8-K: Other Events
12 Feb 2026	8-K: Results of Operations and Financial Condition
03 Nov 2025	8-K: Results of Operations and Financial Condition
04 Aug 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
19 May 2025	8-K: Other Events
14 May 2025	8-K: Submission of Matters to a Vote of Security Holders
05 May 2025	8-K: Results of Operations and Financial Condition
28 Mar 2025	8-K: Other Events
10 Feb 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
20 Dec 2024	8-K: Regulation FD Disclosure
04 Nov 2024	8-K: Results of Operations and Financial Condition
16 Aug 2024	8-K: Entry into a Material Definitive Agreement
01 Aug 2024	8-K: Results of Operations and Financial Condition

Comments